CD163(Antibody) Market - Global Outlook and Forecast 2022-2028

January 2022 | 67 pages | ID: CC8DD12D99F9EN
Market Monitor Global

Abstracts

This report contains market size and forecasts of CD163(Antibody) in Global, including the following market information:

Global CD163(Antibody) Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global CD163(Antibody) market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Above 95% Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of CD163(Antibody) include Thermo Fisher Scientific, R&D Systems, Lifespan Biosciences, Bio-Rad, Abbexa Ltd, Boster Bio, Atlas Antibodies, Biobyt and Novus Biologicals, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the CD163(Antibody) companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global CD163(Antibody) Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global CD163(Antibody) Market Segment Percentages, by Type, 2021 (%)

• Above 95%
• Above 99%
• Others

Global CD163(Antibody) Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global CD163(Antibody) Market Segment Percentages, by Application, 2021 (%)

• Biopharmaceutical Companies
• Hospitals
• Bioscience Research Institutions
• Others

Global CD163(Antibody) Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global CD163(Antibody) Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies CD163(Antibody) revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies CD163(Antibody) revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Thermo Fisher Scientific
• R&D Systems
• Lifespan Biosciences
• Bio-Rad
• Abbexa Ltd
• Boster Bio
• Atlas Antibodies
• Biobyt
• Novus Biologicals
• Aviva Systems Biology
• ProSci
• BioLegend

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 CD163(Antibody) Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global CD163(Antibody) Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL CD163(ANTIBODY) OVERALL MARKET SIZE

2.1 Global CD163(Antibody) Market Size: 2021 VS 2028
2.2 Global CD163(Antibody) Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top CD163(Antibody) Players in Global Market
3.2 Top Global CD163(Antibody) Companies Ranked by Revenue
3.3 Global CD163(Antibody) Revenue by Companies
3.4 Top 3 and Top 5 CD163(Antibody) Companies in Global Market, by Revenue in 2021
3.5 Global Companies CD163(Antibody) Product Type
3.6 Tier 1, Tier 2 and Tier 3 CD163(Antibody) Players in Global Market
  3.6.1 List of Global Tier 1 CD163(Antibody) Companies
  3.6.2 List of Global Tier 2 and Tier 3 CD163(Antibody) Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global CD163(Antibody) Market Size Markets, 2021 & 2028
  4.1.2 Above 95%
  4.1.3 Above 99%
  4.1.4 Others
4.2 By Type - Global CD163(Antibody) Revenue & Forecasts
  4.2.1 By Type - Global CD163(Antibody) Revenue, 2017-2022
  4.2.2 By Type - Global CD163(Antibody) Revenue, 2023-2028
  4.2.3 By Type - Global CD163(Antibody) Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global CD163(Antibody) Market Size, 2021 & 2028
  5.1.2 Biopharmaceutical Companies
  5.1.3 Hospitals
  5.1.4 Bioscience Research Institutions
  5.1.5 Others
5.2 By Application - Global CD163(Antibody) Revenue & Forecasts
  5.2.1 By Application - Global CD163(Antibody) Revenue, 2017-2022
  5.2.2 By Application - Global CD163(Antibody) Revenue, 2023-2028
  5.2.3 By Application - Global CD163(Antibody) Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global CD163(Antibody) Market Size, 2021 & 2028
6.2 By Region - Global CD163(Antibody) Revenue & Forecasts
  6.2.1 By Region - Global CD163(Antibody) Revenue, 2017-2022
  6.2.2 By Region - Global CD163(Antibody) Revenue, 2023-2028
  6.2.3 By Region - Global CD163(Antibody) Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America CD163(Antibody) Revenue, 2017-2028
  6.3.2 US CD163(Antibody) Market Size, 2017-2028
  6.3.3 Canada CD163(Antibody) Market Size, 2017-2028
  6.3.4 Mexico CD163(Antibody) Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe CD163(Antibody) Revenue, 2017-2028
  6.4.2 Germany CD163(Antibody) Market Size, 2017-2028
  6.4.3 France CD163(Antibody) Market Size, 2017-2028
  6.4.4 U.K. CD163(Antibody) Market Size, 2017-2028
  6.4.5 Italy CD163(Antibody) Market Size, 2017-2028
  6.4.6 Russia CD163(Antibody) Market Size, 2017-2028
  6.4.7 Nordic Countries CD163(Antibody) Market Size, 2017-2028
  6.4.8 Benelux CD163(Antibody) Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia CD163(Antibody) Revenue, 2017-2028
  6.5.2 China CD163(Antibody) Market Size, 2017-2028
  6.5.3 Japan CD163(Antibody) Market Size, 2017-2028
  6.5.4 South Korea CD163(Antibody) Market Size, 2017-2028
  6.5.5 Southeast Asia CD163(Antibody) Market Size, 2017-2028
  6.5.6 India CD163(Antibody) Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America CD163(Antibody) Revenue, 2017-2028
  6.6.2 Brazil CD163(Antibody) Market Size, 2017-2028
  6.6.3 Argentina CD163(Antibody) Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa CD163(Antibody) Revenue, 2017-2028
  6.7.2 Turkey CD163(Antibody) Market Size, 2017-2028
  6.7.3 Israel CD163(Antibody) Market Size, 2017-2028
  6.7.4 Saudi Arabia CD163(Antibody) Market Size, 2017-2028
  6.7.5 UAE CD163(Antibody) Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Thermo Fisher Scientific
  7.1.1 Thermo Fisher Scientific Corporate Summary
  7.1.2 Thermo Fisher Scientific Business Overview
  7.1.3 Thermo Fisher Scientific CD163(Antibody) Major Product Offerings
  7.1.4 Thermo Fisher Scientific CD163(Antibody) Revenue in Global Market (2017-2022)
  7.1.5 Thermo Fisher Scientific Key News
7.2 R&D Systems
  7.2.1 R&D Systems Corporate Summary
  7.2.2 R&D Systems Business Overview
  7.2.3 R&D Systems CD163(Antibody) Major Product Offerings
  7.2.4 R&D Systems CD163(Antibody) Revenue in Global Market (2017-2022)
  7.2.5 R&D Systems Key News
7.3 Lifespan Biosciences
  7.3.1 Lifespan Biosciences Corporate Summary
  7.3.2 Lifespan Biosciences Business Overview
  7.3.3 Lifespan Biosciences CD163(Antibody) Major Product Offerings
  7.3.4 Lifespan Biosciences CD163(Antibody) Revenue in Global Market (2017-2022)
  7.3.5 Lifespan Biosciences Key News
7.4 Bio-Rad
  7.4.1 Bio-Rad Corporate Summary
  7.4.2 Bio-Rad Business Overview
  7.4.3 Bio-Rad CD163(Antibody) Major Product Offerings
  7.4.4 Bio-Rad CD163(Antibody) Revenue in Global Market (2017-2022)
  7.4.5 Bio-Rad Key News
7.5 Abbexa Ltd
  7.5.1 Abbexa Ltd Corporate Summary
  7.5.2 Abbexa Ltd Business Overview
  7.5.3 Abbexa Ltd CD163(Antibody) Major Product Offerings
  7.5.4 Abbexa Ltd CD163(Antibody) Revenue in Global Market (2017-2022)
  7.5.5 Abbexa Ltd Key News
7.6 Boster Bio
  7.6.1 Boster Bio Corporate Summary
  7.6.2 Boster Bio Business Overview
  7.6.3 Boster Bio CD163(Antibody) Major Product Offerings
  7.6.4 Boster Bio CD163(Antibody) Revenue in Global Market (2017-2022)
  7.6.5 Boster Bio Key News
7.7 Atlas Antibodies
  7.7.1 Atlas Antibodies Corporate Summary
  7.7.2 Atlas Antibodies Business Overview
  7.7.3 Atlas Antibodies CD163(Antibody) Major Product Offerings
  7.7.4 Atlas Antibodies CD163(Antibody) Revenue in Global Market (2017-2022)
  7.7.5 Atlas Antibodies Key News
7.8 Biobyt
  7.8.1 Biobyt Corporate Summary
  7.8.2 Biobyt Business Overview
  7.8.3 Biobyt CD163(Antibody) Major Product Offerings
  7.8.4 Biobyt CD163(Antibody) Revenue in Global Market (2017-2022)
  7.8.5 Biobyt Key News
7.9 Novus Biologicals
  7.9.1 Novus Biologicals Corporate Summary
  7.9.2 Novus Biologicals Business Overview
  7.9.3 Novus Biologicals CD163(Antibody) Major Product Offerings
  7.9.4 Novus Biologicals CD163(Antibody) Revenue in Global Market (2017-2022)
  7.9.5 Novus Biologicals Key News
7.10 Aviva Systems Biology
  7.10.1 Aviva Systems Biology Corporate Summary
  7.10.2 Aviva Systems Biology Business Overview
  7.10.3 Aviva Systems Biology CD163(Antibody) Major Product Offerings
  7.10.4 Aviva Systems Biology CD163(Antibody) Revenue in Global Market (2017-2022)
  7.10.5 Aviva Systems Biology Key News
7.11 ProSci
  7.11.1 ProSci Corporate Summary
  7.11.2 ProSci Business Overview
  7.11.3 ProSci CD163(Antibody) Major Product Offerings
  7.11.4 ProSci CD163(Antibody) Revenue in Global Market (2017-2022)
  7.11.5 ProSci Key News
7.12 BioLegend
  7.12.1 BioLegend Corporate Summary
  7.12.2 BioLegend Business Overview
  7.12.3 BioLegend CD163(Antibody) Major Product Offerings
  7.12.4 BioLegend CD163(Antibody) Revenue in Global Market (2017-2022)
  7.12.5 BioLegend Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. CD163(Antibody) Market Opportunities & Trends in Global Market
Table 2. CD163(Antibody) Market Drivers in Global Market
Table 3. CD163(Antibody) Market Restraints in Global Market
Table 4. Key Players of CD163(Antibody) in Global Market
Table 5. Top CD163(Antibody) Players in Global Market, Ranking by Revenue (2021)
Table 6. Global CD163(Antibody) Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global CD163(Antibody) Revenue Share by Companies, 2017-2022
Table 8. Global Companies CD163(Antibody) Product Type
Table 9. List of Global Tier 1 CD163(Antibody) Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 CD163(Antibody) Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global CD163(Antibody) Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - CD163(Antibody) Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - CD163(Antibody) Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global CD163(Antibody) Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - CD163(Antibody) Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - CD163(Antibody) Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global CD163(Antibody) Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global CD163(Antibody) Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global CD163(Antibody) Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America CD163(Antibody) Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America CD163(Antibody) Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe CD163(Antibody) Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe CD163(Antibody) Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia CD163(Antibody) Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia CD163(Antibody) Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America CD163(Antibody) Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America CD163(Antibody) Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa CD163(Antibody) Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa CD163(Antibody) Revenue, (US$, Mn), 2023-2028
Table 30. Thermo Fisher Scientific Corporate Summary
Table 31. Thermo Fisher Scientific CD163(Antibody) Product Offerings
Table 32. Thermo Fisher Scientific CD163(Antibody) Revenue (US$, Mn), (2017-2022)
Table 33. R&D Systems Corporate Summary
Table 34. R&D Systems CD163(Antibody) Product Offerings
Table 35. R&D Systems CD163(Antibody) Revenue (US$, Mn), (2017-2022)
Table 36. Lifespan Biosciences Corporate Summary
Table 37. Lifespan Biosciences CD163(Antibody) Product Offerings
Table 38. Lifespan Biosciences CD163(Antibody) Revenue (US$, Mn), (2017-2022)
Table 39. Bio-Rad Corporate Summary
Table 40. Bio-Rad CD163(Antibody) Product Offerings
Table 41. Bio-Rad CD163(Antibody) Revenue (US$, Mn), (2017-2022)
Table 42. Abbexa Ltd Corporate Summary
Table 43. Abbexa Ltd CD163(Antibody) Product Offerings
Table 44. Abbexa Ltd CD163(Antibody) Revenue (US$, Mn), (2017-2022)
Table 45. Boster Bio Corporate Summary
Table 46. Boster Bio CD163(Antibody) Product Offerings
Table 47. Boster Bio CD163(Antibody) Revenue (US$, Mn), (2017-2022)
Table 48. Atlas Antibodies Corporate Summary
Table 49. Atlas Antibodies CD163(Antibody) Product Offerings
Table 50. Atlas Antibodies CD163(Antibody) Revenue (US$, Mn), (2017-2022)
Table 51. Biobyt Corporate Summary
Table 52. Biobyt CD163(Antibody) Product Offerings
Table 53. Biobyt CD163(Antibody) Revenue (US$, Mn), (2017-2022)
Table 54. Novus Biologicals Corporate Summary
Table 55. Novus Biologicals CD163(Antibody) Product Offerings
Table 56. Novus Biologicals CD163(Antibody) Revenue (US$, Mn), (2017-2022)
Table 57. Aviva Systems Biology Corporate Summary
Table 58. Aviva Systems Biology CD163(Antibody) Product Offerings
Table 59. Aviva Systems Biology CD163(Antibody) Revenue (US$, Mn), (2017-2022)
Table 60. ProSci Corporate Summary
Table 61. ProSci CD163(Antibody) Product Offerings
Table 62. ProSci CD163(Antibody) Revenue (US$, Mn), (2017-2022)
Table 63. BioLegend Corporate Summary
Table 64. BioLegend CD163(Antibody) Product Offerings
Table 65. BioLegend CD163(Antibody) Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. CD163(Antibody) Segment by Type in 2021
Figure 2. CD163(Antibody) Segment by Application in 2021
Figure 3. Global CD163(Antibody) Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global CD163(Antibody) Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global CD163(Antibody) Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by CD163(Antibody) Revenue in 2021
Figure 8. By Type - Global CD163(Antibody) Revenue Market Share, 2017-2028
Figure 9. By Application - Global CD163(Antibody) Revenue Market Share, 2017-2028
Figure 10. By Region - Global CD163(Antibody) Revenue Market Share, 2017-2028
Figure 11. By Country - North America CD163(Antibody) Revenue Market Share, 2017-2028
Figure 12. US CD163(Antibody) Revenue, (US$, Mn), 2017-2028
Figure 13. Canada CD163(Antibody) Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico CD163(Antibody) Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe CD163(Antibody) Revenue Market Share, 2017-2028
Figure 16. Germany CD163(Antibody) Revenue, (US$, Mn), 2017-2028
Figure 17. France CD163(Antibody) Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. CD163(Antibody) Revenue, (US$, Mn), 2017-2028
Figure 19. Italy CD163(Antibody) Revenue, (US$, Mn), 2017-2028
Figure 20. Russia CD163(Antibody) Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries CD163(Antibody) Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux CD163(Antibody) Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia CD163(Antibody) Revenue Market Share, 2017-2028
Figure 24. China CD163(Antibody) Revenue, (US$, Mn), 2017-2028
Figure 25. Japan CD163(Antibody) Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea CD163(Antibody) Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia CD163(Antibody) Revenue, (US$, Mn), 2017-2028
Figure 28. India CD163(Antibody) Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America CD163(Antibody) Revenue Market Share, 2017-2028
Figure 30. Brazil CD163(Antibody) Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina CD163(Antibody) Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa CD163(Antibody) Revenue Market Share, 2017-2028
Figure 33. Turkey CD163(Antibody) Revenue, (US$, Mn), 2017-2028
Figure 34. Israel CD163(Antibody) Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia CD163(Antibody) Revenue, (US$, Mn), 2017-2028
Figure 36. UAE CD163(Antibody) Revenue, (US$, Mn), 2017-2028
Figure 37. Thermo Fisher Scientific CD163(Antibody) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. R&D Systems CD163(Antibody) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Lifespan Biosciences CD163(Antibody) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Bio-Rad CD163(Antibody) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Abbexa Ltd CD163(Antibody) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Boster Bio CD163(Antibody) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Atlas Antibodies CD163(Antibody) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Biobyt CD163(Antibody) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Novus Biologicals CD163(Antibody) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Aviva Systems Biology CD163(Antibody) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. ProSci CD163(Antibody) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. BioLegend CD163(Antibody) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)